Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BAXTER INTERNATIONAL INC.

(BAX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/22/2021 09/23/2021 09/24/2021 09/27/2021 09/28/2021 Date
81.05(c) 80.79(c) 80.85(c) 80.57(c) 80.295 Last
2 445 491 2 738 463 2 008 778 2 264 164 809 799 Volume
-1.10% -0.32% +0.07% -0.35% -0.34% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 12 609 M - -
Net income 2021 1 544 M - -
Net Debt 2021 2 500 M - -
P/E ratio 2021 26,4x
Yield 2021 1,30%
Sales 2022 13 206 M - -
Net income 2022 1 822 M - -
Net Debt 2022 2 014 M - -
P/E ratio 2022 22,4x
Yield 2022 1,43%
Capitalization 40 278 M 40 278 M -
EV / Sales 2021 3,39x
EV / Sales 2022 3,20x
Nbr of Employees 50 000
Free-Float 73,0%
More Financials
Company
Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The CompanyÔÇÖs products include renal care, medication delivery, pharmaceuticals, clinical nutrition, advanced surgery and acute therapies. Its renal care offering includes peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services. Its medication delivery offerings include... 
More about the company
Ratings of Baxter International Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about BAXTER INTERNATIONAL INC.
09/27BAXTER INTERNATIONAL : to Host Third-Quarter 2021 Financial Results Conference Call for In..
BU
09/24BAXTER INTERNATIONAL : Dedicated to Our Patients' Needs
PU
09/23BAXTER INTERNATIONAL : Wins US FDA Ok, Rolls Out Ready-to-Use Cardiovascular Medicine Nore..
MT
09/23BAXTER INTERNATIONAL : Wins US FDA Approval For Cardiovascular Drug
MT
09/23BAXTER INTERNATIONAL : Announces U.S. Approval and Launch of Ready-To-Use Cardiovascular M..
PU
09/23BAXTER INTERNATIONAL : Announces U.S. FDA Approval and Launch of Ready-to-use Cardiovascul..
BU
09/23Baxter International Inc. Announces U.S. FDA Approval and Launch of Ready-to-use Cardio..
CI
09/21BAXTER INTERNATIONAL : Raymond James Reinstates Baxter International at Outperform Rating ..
MT
09/17BAXTER INTERNATIONAL : Scholars Award Winners Announced
PU
09/13BAXTER INTERNATIONAL : Issues Urgent Medical Device Correction to Reinforce Important Safe..
AQ
09/13BAXTER INTERNATIONAL : Cowen Upgrades Baxter International to Outperform From Market Perfo..
MT
09/10BAXTER INTERNATIONAL : Issues Urgent Medical Device Correction to Reinforce Important Safe..
PU
09/09BAXTER INTERNATIONAL : Miromatrix Welcomes Dr. John Barry as Vice President of Research an..
AQ
09/08HILL ROM : Downgraded by KeyBanc Following Proposed Acquisition by Baxter
MT
09/07NORTH AMERICAN MORNING BRIEFING : Stocks Likely to -2-
DJ
More news
News in other languages on BAXTER INTERNATIONAL INC.
09/23Baxter International obtient l'autorisation de la FDA et lance un médicament cardiovasc..
09/16WOCHENVORSCHAU : Termine bis 29. September 2021
09/08KeyBanc déclasse Hill-Rom suite à la proposition d'acquisition par Baxter
09/03Le S&P 500 commence le mois de septembre avec une hausse hebdomadaire de 0,6 % malgré u..
09/03L'opération Hillrom proposée par Baxter International comprend une solide augmentation ..
More news
Analyst Recommendations on BAXTER INTERNATIONAL INC.
More recommendations
Chart BAXTER INTERNATIONAL INC.
Duration : Period :
Baxter International Inc. Technical Analysis Chart | BAX | US0718131099 | MarketScreener
Technical analysis trends BAXTER INTERNATIONAL INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 16
Last Close Price 80,57 $
Average target price 93,93 $
Spread / Average Target 16,6%
EPS Revisions
Managers and Directors
JosÚ E. Almeida Chairman, President & Chief Executive Officer
James K. Saccaro Chief Financial Officer & Executive Vice President
Sumant Ramachandra Chief Science & Technology Officer, Senior VP
Tobi Karchmer Vice President-Worldwide Medical
Talvis Love Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
BAXTER INTERNATIONAL INC.0.41%40 278
ABBOTT LABORATORIES10.13%213 766
MEDTRONIC PLC9.91%173 273
BECTON, DICKINSON AND COMPANY0.48%72 208
HOYA CORPORATION29.36%61 370
ALIGN TECHNOLOGY, INC.31.19%55 390